---
title: NeuroPax Event Series
slug: wehealthcare-environment-guide/neuropax-event-series
docTags: 
createdAt: 2026-03-24T13:20:15.846Z
---

## About NeuroPax

NeuroPax™ (neurotrexant) is a prescription medication indicated for the treatment of schizophrenia in adults. In clinical studies, NeuroPax demonstrated efficacy in reducing symptoms of schizophrenia, with a safety profile consistent with its pharmacologic activity. It may be considered as part of an individualized treatment approach based on patient needs and clinical judgment.

## Demo: The NeuroPax Clinical Perspectives Series

The NeuroPax Clinical Perspectives Series is a multi-part educational program designed for healthcare professionals seeking deeper insight into the clinical profile and appropriate integration of NeuroPax into practice. Through expert-led discussions, attendees will explore clinical trial data, mechanism of action, patient selection considerations, safety information, and real-world experience. Each session builds upon the last to provide a comprehensive, evidence-based understanding of NeuroPax within the evolving treatment landscape.

## The Healthcare Provider Story



## The Marketer Story



:::hint{type="danger"}
Make sure to check that your AEM sandbox is currently running.  It takes just a few minutes to de-hibernate it from the [AEM Developer Console](https://dev-console-ns-team-aem-cm-prd-n129965.ethos42-prod-va7.dev.adobeaemcloud.com/#release-cm-p182083-e1919654).  
:::



**Step 1: Create or find your demo profile**

:::hint{type="warning"}
The success of the demo relies on waiting for both audience stitching and near real-time realization of edge audiences in AEP.  Make sure to structure your talk-track to allow time for this to occur.
:::

You have the flexibility to create a new profile or use one of the profiles that exist in the sandbox.